Codon-optimized human Smad7 gene therapy enhances skeletal muscle mass and function in a murine model of Duchenne muscular dystrophy

by Biotech Newsroom


  • Mauro VP. Codon optimization in the production of recombinant biotherapeutics: potential risks and considerations. BioDrugs. 2018;32:69–81.

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Kames J, Alexaki A, Holcomb DD, Santana-Quintero LV, Athey JC, Hamasaki-Katagiri N, et al. TissueCoCoPUTs: novel human tissue-specific codon and codon-pair usage tables based on differential tissue gene expression. J Mol Biol. 2020;432:3369–78.

    Article 
    CAS 
    PubMed 

    Google Scholar
     



  • Source link

    You may also like

    Houston, TX – (EmailWire) — The Biotech Times™ aggregates, publishes and distributes news about the Biotech Industry. In association with EmailWire™, The Biotech Times, helps businesses and organizations in the industry with press release distribution. Press releases are disseminated to journalists, experts, investors, trade publications and other related media outlets. For more information, contact us through the following messaging apps:

    Free Magazines

    Recent Articles

    BioTech Times™ is part of GroupWeb Media Network. © 2026 GroupWeb Media LLC